BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33626351)

  • 1. Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma.
    Farhangdoost N; Horth C; Hu B; Bareke E; Chen X; Li Y; Coradin M; Garcia BA; Lu C; Majewski J
    Cell Rep; 2021 Feb; 34(8):108769. PubMed ID: 33626351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation.
    Rajagopalan KN; Chen X; Weinberg DN; Chen H; Majewski J; Allis CD; Lu C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
    Murali M; Saloura V
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas.
    Papillon-Cavanagh S; Lu C; Gayden T; Mikael LG; Bechet D; Karamboulas C; Ailles L; Karamchandani J; Marchione DM; Garcia BA; Weinreb I; Goldstein D; Lewis PW; Dancu OM; Dhaliwal S; Stecho W; Howlett CJ; Mymryk JS; Barrett JW; Nichols AC; Allis CD; Majewski J; Jabado N
    Nat Genet; 2017 Feb; 49(2):180-185. PubMed ID: 28067913
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
    Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
    Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of
    Bui N; Huang JK; Bojorquez-Gomez A; Licon K; Sanchez KS; Tang SN; Beckett AN; Wang T; Zhang W; Shen JP; Kreisberg JF; Ideker T
    Mol Cancer Ther; 2018 Jul; 17(7):1585-1594. PubMed ID: 29636367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological image and gene expression pattern analysis for predicting molecular features and prognosis of head and neck squamous cell carcinoma.
    Chen L; Zeng H; Zhang M; Luo Y; Ma X
    Cancer Med; 2021 Jul; 10(13):4615-4628. PubMed ID: 33987946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers.
    Lin D; Lin B; Bhanot H; Riou R; Abt NB; Rajagopal J; Saladi SV
    Oral Oncol; 2020 Dec; 111():104930. PubMed ID: 32745900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Modifications in Head and Neck Cancer.
    Gaździcka J; Gołąbek K; Strzelczyk JK; Ostrowska Z
    Biochem Genet; 2020 Apr; 58(2):213-244. PubMed ID: 31712935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.
    Saloura V; Vougiouklakis T; Sievers C; Burkitt K; Nakamura Y; Hager G; van Waes C
    Oral Oncol; 2018 Jun; 81():100-108. PubMed ID: 29884408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.
    Lee M; Nam HY; Kang HB; Lee WH; Lee GH; Sung GJ; Han MW; Cho KJ; Chang EJ; Choi KC; Kim SW; Kim SY
    Cell Death Dis; 2021 Mar; 12(3):250. PubMed ID: 33674559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.
    Chen C; Shin JH; Fang Z; Brennan K; Horowitz NB; Pfaff KL; Welsh EL; Rodig SJ; Gevaert O; Gozani O; Uppaluri R; Sunwoo JB
    Cancer Res; 2023 Aug; 83(16):2645-2655. PubMed ID: 37311054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.
    Li Y; Goldberg EM; Chen X; Xu X; McGuire JT; Leuzzi G; Karagiannis D; Tate T; Farhangdoost N; Horth C; Dai E; Li Z; Zhang Z; Izar B; Que J; Ciccia A; Majewski J; Yoon AJ; Ailles L; Mendelsohn CL; Lu C
    Mol Cell; 2022 Oct; 82(20):3901-3918.e7. PubMed ID: 36206767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.
    Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J
    Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of super-enhancers by KLF4 in human Head and Neck Squamous Cell Carcinoma.
    Tsompana M; Gluck C; Sethi I; Joshi I; Bard J; Nowak NJ; Sinha S; Buck MJ
    Oncogene; 2020 Jan; 39(2):262-277. PubMed ID: 31477832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The H3.3 G34W oncohistone mutation increases K36 methylation by the protein lysine methyltransferase NSD1.
    Bröhm A; Schoch T; Grünberger D; Khella MS; Schuhmacher MK; Weirich S; Jeltsch A
    Biochimie; 2022 Jul; 198():86-91. PubMed ID: 35341929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered histone mark deposition and DNA methylation at homeobox genes in human oral squamous cell carcinoma.
    Marcinkiewicz KM; Gudas LJ
    J Cell Physiol; 2014 Oct; 229(10):1405-16. PubMed ID: 24519855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.